Clinical Trial Update: Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 trial evaluating irradiated donor lymphocyte infusion in patients with relapsed or refractory hematologic cancer o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Cancer
• Solid Tumor

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Cancer | Phase 1 | Status: COMPLETED